triamterene has been researched along with Angiogenesis, Pathologic in 1 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, DF | 1 |
| Farías, EF | 1 |
| Ladeda, V | 1 |
| Davel, L | 1 |
| Puricelli, L | 1 |
| Bal de Kier Joffé, E | 1 |
1 other study available for triamterene and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model.
Topics: Amidines; Amiloride; Animals; Antineoplastic Agents; Cell Division; Diuretics; Enzyme Inhibitors; Fe | 1996 |